
Richard Close
Stock Analyst at Canaccord Genuity
(4.58)
# 971
Out of 4,655 analysts
653
Total ratings
50.2%
Success rate
10.9%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AHCO AdaptHealth | Maintained: Buy | $10 | $5.81 | +72.12% | 31 | Aug 11, 2026 | |
| PHR Phreesia | Maintained: Buy | $16 | $11.58 | +38.17% | 24 | Aug 11, 2026 | |
| PGNY Progyny | Maintained: Buy | $35 | $25.33 | +38.18% | 22 | Aug 11, 2026 | |
| CLOV Clover Health Investments | Maintained: Buy | $5.5 | $4.27 | +28.81% | 31 | Aug 11, 2026 | |
| OMDA Omada Health | Maintained: Buy | $28 | $23.75 | +17.89% | 12 | Aug 11, 2026 | |
| EVH Evolent Health | Maintained: Buy | $7 → $6 | $4.41 | +36.05% | 80 | Aug 10, 2026 | |
| CTEV Claritev | Rated: Buy | $37 → $43 | $35.35 | +21.64% | 4 | Aug 10, 2026 | |
| PRVA Privia Health Group | Maintained: Buy | $34 → $32 | $21.50 | +48.84% | 26 | Aug 7, 2026 | |
| DOCS Doximity | Rated: Buy | $30 → $36 | $24.52 | +46.82% | 28 | Aug 7, 2026 | |
| LFST LifeStance Health Group | Maintained: Buy | $13 | $12.55 | +3.59% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27 → $29 | $28.02 | +3.50% | 64 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $105 | $87.87 | +19.49% | 14 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $10 | $6.54 | +52.91% | 77 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $24.68 | +21.56% | 11 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 → $3 | $1.70 | +76.47% | 33 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5.25 | $5.25 | - | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.7101 | +40.83% | 20 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $13 | $0.0001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $110 | $152.38 | n/a | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.5 → $2 | $0.0001 | n/a | 28 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $89 → $83 | $54.43 | n/a | 45 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $21 | $4.99 | n/a | 60 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $24 | $23.37 | n/a | 12 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $33 | $34.91 | n/a | 1 | Feb 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $190.97 | n/a | 1 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $235.66 | n/a | 1 | Nov 18, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $20 | $9.20 | n/a | 1 | Nov 23, 2009 |
AdaptHealth
Aug 11, 2026
Maintained: Buy
Price Target: $10
Current: $5.81
Upside: +72.12%
Phreesia
Aug 11, 2026
Maintained: Buy
Price Target: $16
Current: $11.58
Upside: +38.17%
Progyny
Aug 11, 2026
Maintained: Buy
Price Target: $35
Current: $25.33
Upside: +38.18%
Clover Health Investments
Aug 11, 2026
Maintained: Buy
Price Target: $5.5
Current: $4.27
Upside: +28.81%
Omada Health
Aug 11, 2026
Maintained: Buy
Price Target: $28
Current: $23.75
Upside: +17.89%
Evolent Health
Aug 10, 2026
Maintained: Buy
Price Target: $7 → $6
Current: $4.41
Upside: +36.05%
Claritev
Aug 10, 2026
Rated: Buy
Price Target: $37 → $43
Current: $35.35
Upside: +21.64%
Privia Health Group
Aug 7, 2026
Maintained: Buy
Price Target: $34 → $32
Current: $21.50
Upside: +48.84%
Doximity
Aug 7, 2026
Rated: Buy
Price Target: $30 → $36
Current: $24.52
Upside: +46.82%
LifeStance Health Group
Aug 6, 2026
Maintained: Buy
Price Target: $13
Current: $12.55
Upside: +3.59%
Aug 5, 2026
Maintained: Hold
Price Target: $27 → $29
Current: $28.02
Upside: +3.50%
Aug 5, 2026
Reiterated: Buy
Price Target: $100 → $105
Current: $87.87
Upside: +19.49%
Jul 30, 2026
Maintained: Buy
Price Target: $11 → $10
Current: $6.54
Upside: +52.91%
Jul 30, 2026
Maintained: Buy
Price Target: $30
Current: $24.68
Upside: +21.56%
Jul 20, 2026
Maintained: Buy
Price Target: $2 → $3
Current: $1.70
Upside: +76.47%
May 12, 2026
Maintained: Hold
Price Target: $5.25
Current: $5.25
Upside: -
May 12, 2026
Maintained: Hold
Price Target: $1
Current: $0.7101
Upside: +40.83%
Mar 10, 2023
Maintained: Buy
Price Target: $50 → $13
Current: $0.0001
Upside: n/a
Feb 27, 2023
Maintained: Hold
Price Target: $110
Current: $152.38
Upside: n/a
May 12, 2022
Maintained: Hold
Price Target: $2.5 → $2
Current: $0.0001
Upside: n/a
Nov 19, 2021
Maintained: Hold
Price Target: $89 → $83
Current: $54.43
Upside: n/a
Nov 8, 2021
Maintained: Buy
Price Target: $18 → $21
Current: $4.99
Upside: n/a
Aug 4, 2021
Maintained: Buy
Price Target: $22 → $24
Current: $23.37
Upside: n/a
Feb 22, 2019
Maintained: Hold
Price Target: $33
Current: $34.91
Upside: n/a
Mar 1, 2018
Reiterated: Buy
Price Target: $135
Current: $190.97
Upside: n/a
Nov 18, 2010
Maintained: Hold
Price Target: n/a
Current: $235.66
Upside: n/a
Nov 23, 2009
Upgraded: Hold
Price Target: $20
Current: $9.20
Upside: n/a